Pietro Campiglia Selected Research

Doxorubicin (Adriamycin)

5/2020	Citrus sinensis and Vitis vinifera Protect Cardiomyocytes from Doxorubicin-Induced Oxidative Stress: Evaluation of Onconutraceutical Potential of Vegetable Smoothies.
6/2011	Design, synthesis, and cytotoxic evaluation of acyl derivatives of 3-aminonaphtho[2,3-b]thiophene-4,9-dione, a quinone-based system.
5/2008	Spiro[(dihydropyrazin-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)]-based cytotoxic agents: structure-activity relationship studies on the substituent at N4-position of the diketopiperazine domain.
4/2007	Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
2/2005	Synthesis and cytotoxic evaluation of novel spirohydantoin derivatives of the dihydrothieno[2,3-b]naphtho-4,9-dione system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Campiglia Research Topics

Disease

31	Neoplasms (Cancer) 06/2022 - 02/2005
9	Breast Neoplasms (Breast Cancer) 05/2020 - 02/2005
7	Inflammation (Inflammations) 01/2022 - 01/2017
7	Infections 12/2021 - 01/2013
6	Hypertension (High Blood Pressure) 01/2022 - 11/2013
4	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2011
3	COVID-19 08/2022 - 08/2021
3	Glioblastoma (Glioblastoma Multiforme) 04/2022 - 06/2011
3	Carcinogenesis 01/2022 - 01/2013
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 12/2020
3	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 06/2010
3	Colitis 01/2020 - 01/2018
3	Heart Failure 12/2019 - 11/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 03/2017
3	Melanoma (Melanoma, Malignant) 07/2016 - 05/2008
3	Hypertrophy 11/2015 - 11/2013
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 05/2008
3	Carcinoma (Carcinomatosis) 06/2010 - 02/2005
2	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 12/2021
2	Ulcerative Colitis 01/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 08/2021
2	Human Influenza (Influenza) 09/2021 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2016
2	Hyperalgesia 10/2020 - 07/2018
2	Non-alcoholic Fatty Liver Disease 05/2020 - 11/2017
2	Adenocarcinoma 05/2020 - 05/2008
2	Necrosis 02/2020 - 01/2016
2	Wounds and Injuries (Trauma) 01/2020 - 12/2019
2	Pain (Aches) 11/2019 - 07/2018
2	Insulin Resistance 03/2019 - 12/2009
2	Atherosclerosis 01/2017 - 03/2014
2	Cardiomegaly (Heart Hypertrophy) 11/2015 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013 - 12/2009
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2022
1	Parotid Neoplasms 06/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Glioma (Gliomas) 01/2022

Drug/Important Bio-Agent (IBA)

12	Peptides (Polypeptides)IBA 09/2021 - 09/2009
8	Pharmaceutical PreparationsIBA 12/2021 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 07/2011
5	Phosphotransferases (Kinase)IBA 11/2020 - 03/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020 - 02/2005
4	LipidsIBA 08/2022 - 03/2017
4	Annexin A1IBA 10/2021 - 01/2020
4	AntioxidantsIBA 05/2020 - 01/2015
4	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2017 - 03/2010
3	Antineoplastic Agents (Antineoplastics)IBA 08/2022 - 06/2010
3	EnzymesIBA 04/2022 - 01/2013
3	Biological ProductsIBA 12/2021 - 10/2012
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 05/2008
3	PolyphenolsIBA 08/2020 - 12/2013
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 10/2016
3	Calmodulin (Calcium-Dependent Activator Protein)IBA 02/2015 - 03/2010
2	AndrogensIBA 08/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2022
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 05/2022 - 01/2017
2	AcidsIBA 01/2022 - 07/2011
2	CalciumIBA 12/2021 - 02/2015
2	QuercetinIBA 08/2021 - 10/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 01/2013
2	Annexin A4IBA 01/2021 - 05/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 05/2016
2	G-Protein-Coupled Receptor Kinase 2IBA 11/2020 - 12/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 07/2018
2	icilinIBA 10/2020 - 07/2018
2	CytokinesIBA 03/2019 - 01/2018
2	Insulin (Novolin)FDA Link 03/2019 - 12/2009
2	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 11/2017
2	CholesterolIBA 01/2019 - 05/2017
2	LactoferrinIBA 10/2018 - 01/2017
2	Protein Tyrosine PhosphatasesIBA 01/2018 - 10/2012
2	Pen(5)-Trp(7)-Orn(8)- urotensin II (4-11)IBA 03/2014 - 07/2009
2	ResveratrolIBA 12/2013 - 09/2013
2	SolutionsIBA 11/2013 - 10/2012
2	indolineIBA 07/2013 - 12/2010
2	(3,3')spiro((hexahydropyrrolo(1,2- a)pyrazine- 1,4- dione)- 6,3'- (2',3'- dihydrothieno(2,3- b)naphtho- 4',9'- dione))IBA 01/2013 - 06/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2013 - 06/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2013 - 07/2011
2	Cisplatin (Platino)FDA LinkGeneric 04/2007 - 02/2005
1	Triglycerides (Triacylglycerol)IBA 06/2022
1	NucleotidesIBA 06/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 06/2022
1	SphingomyelinsIBA 06/2022
1	Angiotensin-Converting Enzyme 2IBA 05/2022
1	Infliximab (Remicade)FDA Link 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	NADPH Oxidase 2IBA 01/2022
1	antiglomerular basement membrane antibodyIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	InterleukinsIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022

Therapy/Procedure

13	Therapeutics 08/2022 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
1	Castration 08/2022
1	Lasers (Laser) 06/2022